United Kingdom Ultrasound Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The United Kingdom ultrasound devices market was valued at USD 371.20 million in 2021 and is projected to register a CAGR of 4.8% during the forecast period (2022-2027).
COVID-19 had an adverse impact on the ultrasound devices market in the United Kingdom. The underfunding of radiologists, radiographers, and imaging technology must be addressed, despite the fact that imaging services are working hard to regain momentum by expanding capacity and rebuilding patient trust. Compared to Computerized Axial Tomography (CT Scan, 0.34 million), Magnetic Resonance Imaging (MRI, 0.34 million), and Diagnostic Ultrasonography (Ultrasound, 0.42 million), all of which will be worth 0.42 million in May 2020, according to the National Health Service England and National Health Service Improvement Statistics 2019-2020. Ultrasounds that might have been used to diagnose ovarian cancer received the majority of general practitioners' referrals. This has a favorable effect on the market in COVID-19. Thus, the market is likely to grow in the future. Similarly, East Surrey Hospital purchased the Samsung HS60 in April 2020 to aid in the fight against Covid-19. Abdominal, vascular, and obstetric scanning are just a few of the portable ultrasound applications that may be carried out using this device. Thus, it is anticipated that such activities will accelerate market expansion.
The development of new products and the rising frequency of chronic illnesses like cardiovascular ailments are anticipated to have the most effects on the growth of the ultrasound devices market in the United Kingdom throughout the course of the study's projected period. An aging and growing population, improved survival rates from heart and circulatory events, and an estimated 7.6 million people in the United Kingdom are living with heart and cardiovascular diseases, according to the British Heart Foundation's July 2021 report. As ultrasound devices are widely used in the monitoring of cardiovascular conditions, these numbers are expected to rise even further. The same report estimates that approximately 1.4 million people (1 million men and 380,000 women) living in the United Kingdom had survived a heart attack, which suggests the high prevalence of heart attack and other risk factors of cardiovascular diseases in the country and is expected to boost the growth of the studied market. Additionally, according to the aforementioned source, over 100,000 hospital admissions each year are due to heart attacks, which is about 280 admissions per day. The introduction of new products is also anticipated to contribute to the market for ultrasound equipment in the UK's long-term growth. For instance, in March 2020, Samsung Ultrasound RS85 Radiology Systems from MIS healthcare were employed by University College London Hospitals (UCLH) in their brand-new Royal National ENT and Eastman Dental Hospital complex on Huntley Street. Thus, the abovementioned factors are expected to increase market growth.
However, stringent regulations are expected to hinder the market growth.
Key Market TrendsHigh-intensity Focused Ultrasound Segment is Expected to Hold a Significant Market Share Over the Forecast PeriodFocused ultrasonic energy is a non-invasive method for tissue ablation, it can be used to treat a variety of solid tumours. High-intensity focused ultrasound is being utilised more frequently to treat both primary and metastatic tumours because it can accurately identify tumours for ablation. Factors such as increasing cancer prevalence and initiatives by key players are expected to increase the market growth. The United Kingdom reported 457,960 new instances of cancer in 2020, according to the Globocan 2020 survey, with prostate, breast, colorectal, lung, and melanoma cancer being the most prevalent forms. The same source also predicts an increase in cancer cases, with predictions for 2030 and 2040 placing the total at 528,902 and 595,909, respectively.
The government's increasing funding initiatives for high-intensity focused ultrasound (HIFU) equipment are anticipated to fuel the industry's expansion in the UK. For instance, the National Health Service (NHS) England has authorized funding for MR-guided Focused Ultrasound for the treatment of patients with Essential Tremors who are unresponsive to medicine beginning in April 2021. As a research collaborator in the creation of this method, St. Mary's Hospital in London is the first facility in the United Kingdom to provide Focused Ultrasound to patients with medication-resistant Essential Tremor. This is expected to increase market growth. A review of high-intensity focused ultrasound (HIFU) in urology was published in November 2021 in the Multidisciplinary Digital Publishing Institute in the United Kingdom. According to this study, HIFU is one of many prostate cancer treatments currently available. It can be used as a salvage treatment after radiotherapy or as the main treatment that can be repeated. In some cases, prostate HIFU is accepted as a localized therapy in urological surgery and may have fewer side effects than other localized therapies. This will result in a rise in the usage of HIFU systems in the United Kingdom's healthcare system for the radiation treatment of prostate cancer and other conditions, which is anticipated to fuel the expansion of high-intensity focused ultrasound systems there.
Hence, the above developments pertaining to high-intensity focused ultrasound systems, it is expected to drive market growth in the country.
Competitive LandscapeThe United Kingdom ultrasound devices market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Canon Medical Systems Corporation, GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers AG, and Koninklijke Philips NV among others.
Additional Benefits:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook